The Fc Receptor Polymorphisms and Expression of Neutrophil Activation Markers in Patients with Sickle Cell Disease from Western India

Table 3

Expression of neutrophil markers among sickle cell disease patients.

	SCD-mild (90); (Mean ± SD)	SCD-severe (61); (Mean ± SD)	SCD-total (151); (Mean ± SD)	Normals (72); (Mean ± SD)	^∗𝑃 value; (SCD-Total versus normals)	^∗𝑃 value; (SCD-Mild versus normals)	^∗𝑃 value; (SCD-Severe versus normals)	^∗𝑃 value; (SCD-Mild versus SCD Severe)
CD16 (MFI)	178.07±90.17	169.84±92.61	174.75±90.95	170.06±94.89	0.72	0.58	0.98	0.58
CD32 (MFI)	30.84±21.73	27.03±21.03	29.30±21.46	13.11±7.05	< 0.0001	< 0.0001	< 0.0001	0.28
CD62L (MFI)	85.08±45.79	100.94±62.24	91.49±53.43	161.94±73.49	< 0.0001	< 0.0001	< 0.0001	0.07

∗Student’s 𝑡 test analysis comparing expression levels in different groups.